Exploring the Future for RSV Prevention & Treatment to Tackle the Surge of Infected Patients

Time: 3:00 pm
day: Pre-Conference Day


Respiratory syncytial virus (RSV) not only infects nearly all infants but is also a massive burden for older adults. Before the COVID pandemic, RSV had predictable seasonality in temperate regions, with numbers peaking in the winter months. In this session, we will consider the implications of the changes to RSV transmission for future prevention strategies. Join this session to discuss:

• The latest advancements in RSV Vaccines

• Ways COVID has changed RSV and what we can do about it

• The race to produce the optimal RSV vaccine for both adults and children